Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Revenue

Kolon TissueGene had revenue of 1.34B KRW in the quarter ending June 30, 2025, with 40.13% growth. This brings the company's revenue in the last twelve months to 5.49B, up 16.53% year-over-year. In the year 2024, Kolon TissueGene had annual revenue of 5.07B with 36.90% growth.

• Revenue (ttm): 5.49B
• Revenue Growth: +16.53%
• P/S Ratio: 815.16
• Revenue / Employee: 189.40M
• Employees: 29
• Market Cap: 4.48T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.07B	1.37B	36.90%
Dec 31, 2023	3.71B	-5.75B	-60.81%
Dec 31, 2022	9.46B	5.45B	136.22%
Dec 31, 2021	4.00B	447.31M	12.58%
Dec 31, 2020	3.56B	521.01M	17.17%